ID   EF2K_HUMAN              Reviewed;         725 AA.
AC   O00418; Q8N588;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 2.
DT   12-OCT-2022, entry version 201.
DE   RecName: Full=Eukaryotic elongation factor 2 kinase;
DE            Short=eEF-2 kinase;
DE            Short=eEF-2K;
DE            EC=2.7.11.20 {ECO:0000269|PubMed:11015200, ECO:0000269|PubMed:9144159};
DE   AltName: Full=Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase;
GN   Name=EEF2K;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND VARIANT
RP   ARG-361.
RC   TISSUE=Glial tumor;
RX   PubMed=9144159; DOI=10.1073/pnas.94.10.4884;
RA   Ryazanov A.G., Ward M.D., Mendola C.E., Pavur K.S., Dorovkov M.V.,
RA   Wiedmann M., Erdjument-Bromage H., Tempst P., Parmer T.G., Prostko C.R.,
RA   Germino F.J., Hait W.N.;
RT   "Identification of a new class of protein kinases represented by eukaryotic
RT   elongation factor-2 kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:4884-4889(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-23 AND ARG-361.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   CATALYTIC ACTIVITY, IDENTIFICATION OF THE CALMODULIN-BINDING REGION,
RP   AUTOPHOSPHORYLATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11015200; DOI=10.1021/bi0007270;
RA   Pavur K.S., Petrov A.N., Ryazanov A.G.;
RT   "Mapping the functional domains of elongation factor-2 kinase.";
RL   Biochemistry 39:12216-12224(2000).
RN   [5]
RP   PHOSPHORYLATION AT SER-359.
RX   PubMed=11500363; DOI=10.1093/emboj/20.16.4360;
RA   Knebel A., Morrice N., Cohen P.;
RT   "A novel method to identify protein kinase substrates: eEF2 kinase is
RT   phosphorylated and inhibited by SAPK4/p38delta.";
RL   EMBO J. 20:4360-4369(2001).
RN   [6]
RP   PHOSPHORYLATION AT SER-366 BY RPS6KA1 AND RPS6KB1, AND MUTAGENESIS OF
RP   SER-366.
RX   PubMed=11500364; DOI=10.1093/emboj/20.16.4370;
RA   Wang X., Li W., Williams M., Terada N., Alessi D.R., Proud C.G.;
RT   "Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase.";
RL   EMBO J. 20:4370-4379(2001).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [8]
RP   FUNCTION, AND PHOSPHORYLATION AT SER-398.
RX   PubMed=14709557; DOI=10.1074/jbc.m309773200;
RA   Browne G.J., Finn S.G., Proud C.G.;
RT   "Stimulation of the AMP-activated protein kinase leads to activation of
RT   eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel
RT   site, serine 398.";
RL   J. Biol. Chem. 279:12220-12231(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-474, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-445, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [11]
RP   PHOSPHORYLATION AT SER-359.
RX   PubMed=18337751; DOI=10.1038/emboj.2008.39;
RA   Smith E.M., Proud C.G.;
RT   "cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino
RT   acid-dependent manner.";
RL   EMBO J. 27:1005-1016(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-348; SER-470; SER-474 AND
RP   SER-477, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; THR-348; SER-445; SER-470
RP   AND SER-474, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION AT SER-78.
RX   PubMed=21112387; DOI=10.1016/j.cellsig.2010.11.011;
RA   Perraud A.L., Zhao X., Ryazanov A.G., Schmitz C.;
RT   "The channel-kinase TRPM7 regulates phosphorylation of the translational
RT   factor eEF2 via eEF2-k.";
RL   Cell. Signal. 23:586-593(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-470, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION AT SER-61; SER-66; SER-78; THR-348; THR-353; SER-366;
RP   SER-445; SER-474 AND SER-491, AND MUTAGENESIS OF SER-78; THR-348 AND
RP   SER-366.
RX   PubMed=22216903; DOI=10.1042/bj20111530;
RA   Pyr Dit Ruys S., Wang X., Smith E.M., Herinckx G., Hussain N., Rider M.H.,
RA   Vertommen D., Proud C.G.;
RT   "Identification of autophosphorylation sites in eukaryotic elongation
RT   factor-2 kinase.";
RL   Biochem. J. 442:681-692(2012).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-70; SER-72; SER-74;
RP   SER-78; SER-243; THR-348; THR-353; SER-435; SER-445; SER-470; SER-474;
RP   SER-477 AND SER-491, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; THR-348; SER-445 AND
RP   SER-474, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-23; ALA-75; MET-291; TRP-433 AND
RP   HIS-609.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Threonine kinase that regulates protein synthesis by
CC       controlling the rate of peptide chain elongation. Upon activation by a
CC       variety of upstream kinases including AMPK or TRPM7, phosphorylates the
CC       elongation factor EEF2 at a single site, renders it unable to bind
CC       ribosomes and thus inactive. In turn, the rate of protein synthesis is
CC       reduced. {ECO:0000269|PubMed:14709557, ECO:0000269|PubMed:9144159}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[translation elongation factor 2] + ATP = [translation
CC         elongation factor 2]-phosphate + ADP + H(+); Xref=Rhea:RHEA:21436,
CC         Rhea:RHEA-COMP:11268, Rhea:RHEA-COMP:11269, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43176, ChEBI:CHEBI:68546,
CC         ChEBI:CHEBI:456216; EC=2.7.11.20;
CC         Evidence={ECO:0000269|PubMed:11015200, ECO:0000269|PubMed:9144159};
CC   -!- ACTIVITY REGULATION: Undergoes calcium/calmodulin-dependent
CC       intramolecular autophosphorylation, and this results in it becoming
CC       partially calcium/calmodulin-independent. {ECO:0000250}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.2 uM for EEF2 {ECO:0000269|PubMed:11015200};
CC         Vmax=4 nmol/min/mg enzyme {ECO:0000269|PubMed:11015200};
CC   -!- SUBUNIT: Monomer or homodimer (Probable). Interacts with
CC       Calmodulin/CALM1; this interaction is strictly required for
CC       phosphorylation activity (PubMed:11015200).
CC       {ECO:0000269|PubMed:11015200, ECO:0000305}.
CC   -!- PTM: Autophosphorylated at multiple residues, Thr-348 being the major
CC       site. Phosphorylated by AMP-activated protein kinase AMPK at Ser-398
CC       leading to EEF2K activation and protein synthesis inhibition.
CC       Phosphorylated by TRPM7 at Ser-78 resulting in improved protein
CC       stability, higher EE2F phosphorylated and subsequently reduced rate of
CC       protein synthesis. Phosphorylation by other kinases such as CDK1 and
CC       MAPK13 at Ser-359 or RPS6KA1 and RPS6KB1 at Ser-366 instead decrease
CC       EEF2K activity and promote protein synthesis.
CC       {ECO:0000269|PubMed:11015200, ECO:0000269|PubMed:11500363,
CC       ECO:0000269|PubMed:11500364, ECO:0000269|PubMed:14709557,
CC       ECO:0000269|PubMed:18337751, ECO:0000269|PubMed:21112387,
CC       ECO:0000269|PubMed:22216903}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Alpha-type
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U93850; AAB58270.1; -; mRNA.
DR   EMBL; AC009034; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032665; AAH32665.1; -; mRNA.
DR   CCDS; CCDS10604.1; -.
DR   RefSeq; NP_037434.1; NM_013302.3.
DR   RefSeq; XP_005276554.1; XM_005276497.3.
DR   RefSeq; XP_016878682.1; XM_017023193.1.
DR   PDB; 5J8H; NMR; -; B=74-100.
DR   PDB; 5KS5; NMR; -; A=627-725.
DR   PDB; 6NX4; NMR; -; A=562-725.
DR   PDB; 7SHQ; X-ray; 2.34 A; A=70-358, A=490-725.
DR   PDBsum; 5J8H; -.
DR   PDBsum; 5KS5; -.
DR   PDBsum; 6NX4; -.
DR   PDBsum; 7SHQ; -.
DR   AlphaFoldDB; O00418; -.
DR   SMR; O00418; -.
DR   BioGRID; 118953; 55.
DR   BioGRID; 3193665; 1.
DR   ELM; O00418; -.
DR   IntAct; O00418; 20.
DR   MINT; O00418; -.
DR   STRING; 9606.ENSP00000263026; -.
DR   BindingDB; O00418; -.
DR   ChEMBL; CHEMBL5026; -.
DR   GuidetoPHARMACOLOGY; 2014; -.
DR   GlyGen; O00418; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O00418; -.
DR   MetOSite; O00418; -.
DR   PhosphoSitePlus; O00418; -.
DR   BioMuta; EEF2K; -.
DR   EPD; O00418; -.
DR   jPOST; O00418; -.
DR   MassIVE; O00418; -.
DR   MaxQB; O00418; -.
DR   PaxDb; O00418; -.
DR   PeptideAtlas; O00418; -.
DR   PRIDE; O00418; -.
DR   ProteomicsDB; 47876; -.
DR   Antibodypedia; 25835; 465 antibodies from 33 providers.
DR   DNASU; 29904; -.
DR   Ensembl; ENST00000263026.10; ENSP00000263026.5; ENSG00000103319.12.
DR   GeneID; 29904; -.
DR   KEGG; hsa:29904; -.
DR   MANE-Select; ENST00000263026.10; ENSP00000263026.5; NM_013302.5; NP_037434.2.
DR   UCSC; uc002dki.4; human.
DR   CTD; 29904; -.
DR   DisGeNET; 29904; -.
DR   GeneCards; EEF2K; -.
DR   HGNC; HGNC:24615; EEF2K.
DR   HPA; ENSG00000103319; Tissue enhanced (skin).
DR   MIM; 606968; gene.
DR   neXtProt; NX_O00418; -.
DR   OpenTargets; ENSG00000103319; -.
DR   PharmGKB; PA134992891; -.
DR   VEuPathDB; HostDB:ENSG00000103319; -.
DR   eggNOG; ENOG502QVA3; Eukaryota.
DR   GeneTree; ENSGT00940000157839; -.
DR   HOGENOM; CLU_382143_0_0_1; -.
DR   InParanoid; O00418; -.
DR   OMA; LEAIITM; -.
DR   OrthoDB; 741011at2759; -.
DR   PhylomeDB; O00418; -.
DR   TreeFam; TF316085; -.
DR   BRENDA; 2.7.11.20; 2681.
DR   PathwayCommons; O00418; -.
DR   Reactome; R-HSA-166208; mTORC1-mediated signalling.
DR   SignaLink; O00418; -.
DR   SIGNOR; O00418; -.
DR   BioGRID-ORCS; 29904; 9 hits in 1112 CRISPR screens.
DR   ChiTaRS; EEF2K; human.
DR   GeneWiki; EEF2K; -.
DR   Pharos; O00418; Tchem.
DR   PRO; PR:O00418; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; O00418; protein.
DR   Bgee; ENSG00000103319; Expressed in skin of leg and 102 other tissues.
DR   ExpressionAtlas; O00418; baseline and differential.
DR   Genevisible; O00418; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0004686; F:elongation factor-2 kinase activity; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0008135; F:translation factor activity, RNA binding; TAS:ProtInc.
DR   GO; GO:0071454; P:cellular response to anoxia; IEA:Ensembl.
DR   GO; GO:1990416; P:cellular response to brain-derived neurotrophic factor stimulus; IEA:Ensembl.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IEA:Ensembl.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IEA:Ensembl.
DR   GO; GO:0045807; P:positive regulation of endocytosis; IEA:Ensembl.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0031952; P:regulation of protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0002931; P:response to ischemia; IEA:Ensembl.
DR   GO; GO:1990637; P:response to prolactin; IEA:Ensembl.
DR   GO; GO:0006414; P:translational elongation; TAS:ProtInc.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR017400; eEF-2K.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR004166; MHCK_EF2_kinase.
DR   InterPro; IPR006597; Sel1-like.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   Pfam; PF02816; Alpha_kinase; 1.
DR   Pfam; PF08238; Sel1; 3.
DR   PIRSF; PIRSF038139; Elongation_factor_2_kinase; 1.
DR   SMART; SM00811; Alpha_kinase; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51158; ALPHA_KINASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Calcium; Calmodulin-binding;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22223895"
FT   CHAIN           2..725
FT                   /note="Eukaryotic elongation factor 2 kinase"
FT                   /id="PRO_0000086936"
FT   DOMAIN          116..326
FT                   /note="Alpha-type protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00501"
FT   REGION          1..53
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          81..94
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000269|PubMed:11015200"
FT   REGION          352..405
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          423..477
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        379..405
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        423..474
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         296..302
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22223895"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:15144186,
FT                   ECO:0007744|PubMed:16964243, ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         61
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:22216903"
FT   MOD_RES         66
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:22216903"
FT   MOD_RES         70
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         71
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08796"
FT   MOD_RES         72
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         74
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         78
FT                   /note="Phosphoserine; by autocatalysis and TRPM7"
FT                   /evidence="ECO:0000269|PubMed:21112387,
FT                   ECO:0000269|PubMed:22216903, ECO:0007744|PubMed:23186163"
FT   MOD_RES         243
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         348
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:22216903,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         353
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:22216903,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         359
FT                   /note="Phosphoserine; by MAPK13 and CDK1"
FT                   /evidence="ECO:0000269|PubMed:11500363,
FT                   ECO:0000269|PubMed:18337751"
FT   MOD_RES         366
FT                   /note="Phosphoserine; by autocatalysis, RPS6KA1 and
FT                   RPS6KB1"
FT                   /evidence="ECO:0000269|PubMed:11500364,
FT                   ECO:0000269|PubMed:22216903"
FT   MOD_RES         392
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08796"
FT   MOD_RES         398
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:14709557"
FT   MOD_RES         435
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         445
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:22216903,
FT                   ECO:0007744|PubMed:16964243, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         470
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         474
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:22216903,
FT                   ECO:0007744|PubMed:17081983, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         477
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         491
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:22216903,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         500
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P70531"
FT   VARIANT         23
FT                   /note="H -> R (in dbSNP:rs9935059)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_033915"
FT   VARIANT         75
FT                   /note="P -> A (in dbSNP:rs17841292)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_033916"
FT   VARIANT         291
FT                   /note="T -> M (in a colorectal adenocarcinoma sample;
FT                   somatic mutation; dbSNP:rs147978363)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041534"
FT   VARIANT         361
FT                   /note="Q -> R (in dbSNP:rs4783453)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9144159"
FT                   /id="VAR_058405"
FT   VARIANT         433
FT                   /note="R -> W (in dbSNP:rs56137739)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041535"
FT   VARIANT         609
FT                   /note="D -> H"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041536"
FT   MUTAGEN         78
FT                   /note="S->A: Decreased kinase activity."
FT                   /evidence="ECO:0000269|PubMed:22216903"
FT   MUTAGEN         348
FT                   /note="T->A: Decreased kinase activity."
FT                   /evidence="ECO:0000269|PubMed:22216903"
FT   MUTAGEN         366
FT                   /note="S->A: Abrogates phosphorylation by RPS6KB1."
FT                   /evidence="ECO:0000269|PubMed:11500364,
FT                   ECO:0000269|PubMed:22216903"
FT   MUTAGEN         366
FT                   /note="S->A: Decreased kinase activity."
FT                   /evidence="ECO:0000269|PubMed:11500364,
FT                   ECO:0000269|PubMed:22216903"
FT   STRAND          78..80
FT                   /evidence="ECO:0007829|PDB:5J8H"
FT   HELIX           82..94
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           100..102
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           104..106
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          110..118
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   TURN            119..122
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          123..133
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          138..140
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          142..151
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          155..157
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   TURN            162..165
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          166..174
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           178..199
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          213..216
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          218..220
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          225..230
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          242..244
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          248..250
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           253..265
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   TURN            266..268
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          269..273
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          276..278
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          286..291
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           301..311
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           316..320
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           330..338
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           502..511
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           522..535
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   TURN            536..539
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           548..560
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           564..574
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   TURN            581..584
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           591..606
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           610..622
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   TURN            624..626
FT                   /evidence="ECO:0007829|PDB:6NX4"
FT   HELIX           634..645
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          649..653
FT                   /evidence="ECO:0007829|PDB:6NX4"
FT   HELIX           664..677
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   STRAND          680..682
FT                   /evidence="ECO:0007829|PDB:6NX4"
FT   HELIX           686..702
FT                   /evidence="ECO:0007829|PDB:7SHQ"
FT   HELIX           706..720
FT                   /evidence="ECO:0007829|PDB:7SHQ"
SQ   SEQUENCE   725 AA;  82144 MW;  9D2900E50EFF12DA CRC64;
     MADEDLIFRL EGVDGGQSPR AGHDGDSDGD SDDEEGYFIC PITDDPSSNQ NVNSKVNKYY
     SNLTKSERYS SSGSPANSFH FKEAWKHAIQ KAKHMPDPWA EFHLEDIATE RATRHRYNAV
     TGEWLDDEVL IKMASQPFGR GAMRECFRTK KLSNFLHAQQ WKGASNYVAK RYIEPVDRDV
     YFEDVRLQME AKLWGEEYNR HKPPKQVDIM QMCIIELKDR PGKPLFHLEH YIEGKYIKYN
     SNSGFVRDDN IRLTPQAFSH FTFERSGHQL IVVDIQGVGD LYTDPQIHTE TGTDFGDGNL
     GVRGMALFFY SHACNRICES MGLAPFDLSP RERDAVNQNT KLLQSAKTIL RGTEEKCGSP
     QVRTLSGSRP PLLRPLSENS GDENMSDVTF DSLPSSPSSA TPHSQKLDHL HWPVFSDLDN
     MASRDHDHLD NHRESENSGD SGYPSEKRGE LDDPEPREHG HSYSNRKYES DEDSLGSSGR
     VCVEKWNLLN SSRLHLPRAS AVALEVQRLN ALDLEKKIGK SILGKVHLAM VRYHEGGRFC
     EKGEEWDQES AVFHLEHAAN LGELEAIVGL GLMYSQLPHH ILADVSLKET EENKTKGFDY
     LLKAAEAGDR QSMILVARAF DSGQNLSPDR CQDWLEALHW YNTALEMTDC DEGGEYDGMQ
     DEPRYMMLAR EAEMLFTGGY GLEKDPQRSG DLYTQAAEAA MEAMKGRLAN QYYQKAEEAW
     AQMEE
//
